ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEMO Hemogenyx Pharmaceuticals Plc

1.55
-0.015 (-0.96%)
Last Updated: 15:17:40
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.015 -0.96% 1.55 1.536 1.598 1.55 1.55 1.55 4,707,352 15:17:40
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.43 17.7M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.57p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.70 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.43.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 13251 to 13271 of 13425 messages
Chat Pages: 537  536  535  534  533  532  531  530  529  528  527  526  Older
DateSubjectAuthorDiscuss
05/3/2024
17:15
Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented:

"We are extremely pleased to have raised these funds to allow us to progress our lead asset, HEMO-CAR-T, to clinical trials. This is a key development that represents the progression of Hemogenyx Pharmaceuticals to become a clinical stage company and the fundraise was crucial to enable us to progress toward clinical trials, the essential next step for the development of HEMO-CAR-T."

apotheki
05/3/2024
17:05
The funds have been raised to allow the Company to progress HEMO-CAR-T to phase 1 clinical trials.
apotheki
05/3/2024
17:05
The Placing will be used to facilitate the development of the Company's Chimeric Antigen Receptor T-cells ("HEMO-CAR-T") for the treatment of acute myeloid leukaemia ("AML")
apotheki
05/3/2024
15:31
What's the next step for HEMO
lemonadestand1
05/3/2024
14:25
Hey J J the most likely reason for volumes starting to drop off is in my opinion that the shares that required forward selling [ahead of tomorrow] have now already for the most part [95%+] been sold
apotheki
05/3/2024
14:20
An application is being made to the London Stock Exchange Main Market and admission of the Placing Shares to trading is expected on or around 6 March 2024
apotheki
05/3/2024
13:07
Volumes dropping off now
jibba jabber
05/3/2024
09:31
Vladislav Sandler is a deceiver, he has been deceiving shareholder for many many years, first he destroyed shareholder value by signing CLN agreement than every time he falsify and build hype to pump the price so he can raise more funds just to pay his own and his incompetent teams salaries.
trader4ever
04/3/2024
10:05
And that is far too low given where the company are currently and more importantly where the company are potentially headed.

Additionally the company are extremely undervalued when compared to their peer group especially in the USA

apotheki
04/3/2024
09:39
2p gives a MC valuation of over £26 million.
countbasie1
02/3/2024
10:20
So with all the forward selling from the placement that has already occurred [plus of course Monday & Tuesday] the coast should be for the most part a lot clearer from next Wednesday [6th March] for the shares to move back on up from the sub 2p levels!
apotheki
02/3/2024
10:15
Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented:

"We are extremely pleased to have raised these funds to allow us to progress our lead asset, HEMO-CAR-T, to clinical trials. This is a key development that represents the progression of Hemogenyx Pharmaceuticals to become a clinical stage company and the fundraise was crucial to enable us to progress toward clinical trials, the essential next step for the development of HEMO-CAR-T.

I would like to thank new and existing shareholders for their support and for contributing to this sizeable fundraise in difficult market conditions. The recent lifting of the clinical hold by the FDA on our HEMO-CAR-T programme followed a great effort from everyone at Hemogenyx Pharmaceuticals for which I am very grateful."

apotheki
02/3/2024
10:10
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that it raised US$4.2 million....

An application is being made to the London Stock Exchange Main Market and admission of the Placing Shares to trading is expected on or around 6 March 2024

apotheki
01/3/2024
15:20
Marcucci added, "This novel mechanism and the targeting by City of Hope's homegrown approach will allow us to eliminate otherwise dormant leukemia stem cells. Our hope and goal is that eradication of leukemia stem cells will decrease and even eliminate the risk of disease relapse in patients with AML, but much more research needs to be done to translate our preclinical research into human treatment."

Try reading the articles you post Dreamy chops

saint in exile
01/3/2024
14:20
Now that the main TROLLs have left this main HEMO thread why don't you decent posters engage over here instead of on the dark side?
apotheki
01/3/2024
14:17
saint in exile 1 Mar '24 - 11:57 - 8809 of 8811

I suggest you research some of the buy outs for T CAR companies in recent times.The sector is very much in its infancy

apotheki
01/3/2024
12:02
Be my guest & buy above the market value ⚓
dreamtwister
01/3/2024
11:58
If it wasnt cancer wouldn't exist
saint in exile
01/3/2024
11:57
I suggest you research some of the buy outs for T CAR companies in recent times.The sector is very much in its infancy
saint in exile
01/3/2024
11:35
saint in exile 1 Mar '24 - 11:19 - 8806 of 8806

So what.You need funding to unlock this tech.who knew.Some of us are more interested in the end game and yes that involves placings and risk.You either take the chance or you dont.Its not like some kind of con trick.Vlad is really trying to save lives.Maybe even your mums Dreamyif you have one

apotheki
01/3/2024
11:19
So what.You need funding to unlock this tech.who knew.Some of us are more interested in the end game and yes that involves placings and risk.You either take the chance or you dont.Its not like some kind of con trick.Vlad is really trying to save lives.Maybe even your mums Dreamyif you have one
saint in exile
Chat Pages: 537  536  535  534  533  532  531  530  529  528  527  526  Older

Your Recent History

Delayed Upgrade Clock